Compliance
Compliance for the rituximab group was defined as receipt of five doses of rituximab (unless withheld for IgG <3 g/L) and no oral immunosuppressive agents administered. Compliance in the azathioprine group was defined as ongoing receipt of azathioprine, methotrexate or mycophenolate mofetil between months 4 and 24.